We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Results 1 to 5 of 9
Most popular |Most recent

Plavix Decision Raises Questions About Learned Intermediary Doctrine

USA - November 16 2017 A federal judge in New Jersey recently granted summary judgment to Plavix drug makers Bristol Myers-Squibb Company (“BMS”), Sanofi-Aventis U.S., L.L.C...

Stefanie Colella-Walsh.

Trump Declares Opioid Epidemic a Public Health Emergency

USA - October 31 2017 From 2000 to 2015, more than half a million people died of drug overdoses across the country and most of those deaths involved opioids, according to...

Stefanie Colella-Walsh.

New Jersey Files Lawsuit Against Opioid Manufacturer

USA - October 26 2017 Attorney General Christopher S. Porrino recently announced that New Jersey has filed a lawsuit against Insys Therapeutics, Inc. charging that the...

Stefanie Colella-Walsh.

New Evidence of Amputation Risk Impacts Invokana MDL

USA - October 5 2017 In July 2017, an FDA-mandated cardiovascular outcomes trial (CANVAS) reported that Invokana use roughly doubles the risk of lower limb amputation...

Third Circuit Clarifies Pleading Standard in Pay-For-Delay Suits

USA - September 12 2017 A Third Circuit opinion in the In re: Lipitor Antitrust Litigation reinstated the pay-for-delay lawsuit accusing pharmaceutical companies Pfizer Inc...